XML 26 R17.htm IDEA: XBRL DOCUMENT v3.24.3
Notes to the interim condensed consolidated statement of (income) loss (Tables)
6 Months Ended
Jun. 30, 2024
Notes to the interim condensed consolidated statement of (income) loss  
Schedule of revenues and other income

Operating income

Six months ended

In thousands of euros

    

June 30, 2024

    

June 30, 2023

Revenue

 

41

1,901

Total revenue

 

41

1,901

Tax credits

 

2,630

3,631

Subsidies

 

5

3

Other

 

58

1,087

Other income

 

2,693

4,721

Total revenue and other income

 

2,734

6,622

Schedule of research and development, marketing

Research and

Marketing – 

General and

Six months ended June 30, 2024

development

Business

administrative

In thousands of euros

    

costs

    

development

    

expenses

    

Total

Disposables

 

(887)

 

 

 

(887)

Energy and liquids

 

(447)

 

 

 

(447)

Patents

 

(643)

 

 

 

(643)

Studies

 

(34,073)

 

 

 

(34,073)

Maintenance

 

(526)

 

 

 

(526)

Fees

 

(118)

 

(2)

 

(2,675)

 

(2,795)

IT systems

 

(405)

 

(6)

 

(33)

 

(444)

Support costs (including taxes)

 

 

 

(375)

 

(375)

Personnel costs

 

(7,637)

 

(153)

 

(2,600)

 

(10,391)

Depreciation, amortization and provisions

 

(1,732)

 

 

(122)

 

(1,854)

Insurances

(921)

(921)

Other operating expenses

 

(352)

 

(437)

 

(975)

 

(1,764)

Total operating expenses

 

(46,822)

 

(598)

 

(7,701)

 

(55,122)

Research and

Marketing – 

General and

Six months ended June 30, 2023

development

Business

administrative

en milliers d'euros

    

costs

    

development

    

expenses

    

Total

Disposables

 

(943)

 

 

 

(943)

Energy and liquids

 

(479)

 

 

 

(479)

Patents

 

(257)

 

 

 

(257)

Studies

 

(42,847)

 

 

 

(42,847)

Maintenance

 

(459)

 

 

 

(459)

Fees

 

(61)

 

 

(1,884)

 

(1,945)

IT systems

 

(440)

 

(9)

 

(50)

 

(498)

Support costs (including taxes)

 

 

 

(343)

 

(343)

Personnel costs

 

(7,065)

 

(126)

 

(2,347)

 

(9,538)

Depreciation, amortization and provisions

 

(1,061)

 

 

(104)

 

(1,166)

Insurances

(1,121)

(1,121)

Other operating expenses

 

(450)

 

(570)

 

(964)

 

(1,985)

Total operating expenses

 

(54,062)

 

(705)

 

(6,812)

 

(61,580)

Schedule of personnel costs and headcount

    

    

Marketing -

    

    

Research and

Business

General and

Six months ended June 30, 2024

development

development

administrative

In thousands of euros

costs

expenses

expenses

Total

Wages, salaries and similar costs

 

(4,824)

 

(120)

 

(1,237)

 

(6,181)

Payroll taxes

 

(1,312)

 

(10)

 

(563)

 

(1,886)

Provisions for retirement benefit obligations

 

(51)

 

 

(35)

 

(86)

Share-based payments

 

(1,450)

 

(24)

 

(765)

 

(2,238)

Total personnel costs

 

(7,637)

 

(153)

 

(2,600)

 

(10,391)

    

    

Marketing -

    

    

Research and

Business

General and

Six months ended June 30, 2023

development

development

administrative

In thousands of euros

    

costs

    

expenses

    

expenses

    

Total

Wages, salaries and similar costs

 

(4,399)

 

(104)

 

(1,191)

 

(5,694)

Payroll taxes

 

(1,222)

 

(10)

 

(476)

 

(1,708)

Provisions for retirement benefit obligations

 

(61)

 

 

(29)

 

(90)

Share-based payments

 

(1,383)

 

(13)

 

(650)

 

(2,046)

Total personnel costs

 

(7,065)

 

(126)

 

(2,347)

 

(9,538)

Schedule of other operating income and expenses

    

Six months ended

In thousands of euros

    

June 30, 2024

    

June 30, 2023

Other operating income

160

Other operating expenses

(22)

(44)

Other operating income and expenses

 

138

(44)

Schedule of financial income and expenses

    

Six months ended

In thousands of euros

    

June 30, 2024

    

June 30, 2023

Income from cash equivalents

 

430

564

Foreign exchange gains

 

157

187

Gain on fair value variation

8,506

1,623

Total financial income

 

9,093

2,373

Interest cost

 

(5,218)

(1,941)

Foreign exchange losses

(323)

(683)

Other financial expenses

 

(46)

(23)

Total financial expenses

 

(5,586)

(2,646)

Net financial income

 

3,507

(273)

Schedule of share of net profit - Equity method

(in thousands of euros) For the period started January 1, 2024, to June 30, 2024

 

Research and development costs

 

(51)

General and administrative expenses

 

(1,475)

Net operating loss

 

(1,526)

Financial income

 

20

Financial expenses

 

(3)

Net financial income

 

17

Income (expense) tax

 

Net loss for the period

 

(1,509)

Exchange difference on translation of foreign operations

 

(1,964)

Items that will be reclassified subsequently to profit or loss

 

(3,473)

Total comprehensive loss

 

(3,473)

Group's share in

 

14.64

%

Share of net profit

 

235

Elimination of downstream sales

 

(66)

Share of net profit - Equity method

 

168

Schedule of basic and diluted loss per share

    

Six months ended

    

June 30, 2024

    

June 30, 2023

Net loss for the period

 

(49,029)

(55,269)

Weighted average number of shares outstanding used to calculate basic/diluted loss per share(1)

 

51,982,093

42,044,796

Basic/diluted loss per share

 

(0.94)

(1.31)

(1)

In accordance with IAS 33.19, basic/diluted earnings per share exclude treasury shares held by the Group as of June 30, 2024 and 2023.